Abstract
Conceptual models of epithelial carcinogenesis typically depict a sequence of heritable changes that give rise to a population of cells possessing the hallmarks of invasive cancer. We propose the evolutionary dynamics that give rise to the phenotypic properties of malignant cells must be understood within the context of specific selection forces generated by the microenvironment. This can be accomplished by using an “inverse problem” approach in which we use observed typical phenotypic traits of primary and metastatic cancers to infer the evolutionary dynamics. This has led to the hypothesis that heritable changes in genes controlling cellular proliferation, apoptosis, and senescence, while necessary, are not usually sufficient to produce an invasive cancer. In addition to these evolutionary steps, we propose that the common observation of aerobic glycolysis in human cancers indicates, via the inverse problem analysis, that adaptation to hypoxia and acidosis must be a major component of the carcinogenic sequence. The details of the hypothesis are based on recognition that premalignant populations evolve within ducts and remain separated from their blood supply by a basement membrane. As tumor cells proliferate into the lumen, diffusion-reaction kinetics enforced by this separation result in hypoxia and acidosis in regions of the tumor the most distant from the basement membrane. This produces new evolutionary selection forces that promote constitutive upregulation of glycolysis and resistance to acid-induced toxicity. We hypothesize that these phenotypic adaptations are critical late steps in carcinogenesis conferring proliferative advantages even in normoxic conditions by allowing the population to produce an acidic environment (through aerobic glycolysis) which is toxic to other local cell populations and promotes extracellular matrix degradation, increasing invasiveness.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fearon, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759–767.
Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57–70.
Anderson, A. R., Weaver, A. M., Cummings, P. T., & Quaranta, V. (2006). Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell, 127, 905–915.
Gatenby, R. A., & Vincent, T. L. (2003). An evolutionary model of carcinogenesis. Cancer Research, 63, 6212–6220.
Gatenby, R. A., & Gillies, R. J. (2004). Why do cancers have high aerobic glycolysis? Nature Reviews. Cancer, 4, 891–899.
Gatenby, R. A., & Gawlinski, E. T. (2003). The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Research, 63, 3847–3854.
Gatenby, R. A., & Frieden, B. R. (2004). Information dynamics in carcinogenesis and tumor growth. Mutation Research, 568, 259–273.
Bhujwalla, Z. M., Artemov, D., Ballesteros, P., Cerdan, S., Gillies, R. J. (2002). Solaiyappan M: Combined vascular and extracellular pH imaging of solid tumors. NMR in Biomedecine, 15, 114–119.
Bhujwalla, Z. M., Artemov, D., Aboagye, E., Ackerstaff, E., Gillies, R. J., Natarajan, K., et al. (2001). The physiological environment in cancer vascularization, invasion and metastasis. Novartis Foundation Symposium, 240, 23–38.
Gillies, R. J., Raghunand, N., Karczmar, G. S., & Bhujwalla, Z. M. (2002). MRI of the tumor microenvironment. Journal of Magnetic Resonance Imaging, 16, 430–450.
Raghunand, N., Gatenby, R. A., & Gillies, R. J. (2003). Microenvironmental and cellular consequences of altered blood flow in tumours. British Journal of Radiology, 76(1), S11–S22.
Tatum, J. L., Kelloff, G. J., Gillies, R. J., Arbeit, J. M., Brown, J. M., Chao, K. S., et al. (2006). Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. International Journal of Radiation Biology, 82, 699–757.
Smallbone, K., Gatenby, R. A., Gillies, R. J., Maini, P. K., & Gavaghan, D. J. (2007). Metabolic changes during carcinogenesis: Potential impact on invasiveness. Journal of Theoretical Biology, 244, 703–713.
Ishikawa, F. (1997). Telomere crisis, the driving force in cancer cell evolution. Biochemical and Biophysical Research Communications, 230, 1–6.
Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., et al. (2004). In situ analyses of genome instability in breast cancer. Nature Genetics, 36, 984–988.
Warburg, O. (1930). Über den Stoffwechsel der Tumoren.
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., et al. (2005). Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clinical Cancer Research, 11, 2785–2808.
Braun, R. D., Lanzen, J. L., & Dewhirst, M. W. (1999). Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. American Journal of Physiology, 277, t-68.
Baudelet, C., Cron, G. O., Ansiaux, R., Crokart, N., DeWever, J., Feron, O., et al. (2006). The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors. NMR in Biomedicine, 19, 69–76.
Martinive, P., Defresne, F., Bouzin, C., Saliez, J., Lair, F., Gregoire, V., et al. (2006). Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Cancer Research, 66, 11736–11744.
Martinive, P., De, W. J., Bouzin, C., Baudelet, C., Sonveaux, P., Gregoire, V., et al. (2006). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery. Mol Cancer Ther, 5, 1620–1627.
Zhou, J., Schmid, T., Schnitzer, S., Brune, B. (2006). Tumor hypoxia and cancer progression. Cancer Letter, 237, 10–21.
Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., & Gillies, R. J. (2005). Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia, 7, 324–330.
Schornack, P. A., & Gillies, R. J. (2003). Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia (New York), 5, 135–145.
Gillies, R. J., Raghunand, N., Garcia-Martin, M. L., & Gatenby, R. A. (2004). pH imaging. A review of pH measurement methods and applications in cancers. IEEE Engineering in Medicine and Biology Magazine, 23, 57–64.
Williams, A. C., Collard, T. J., & Paraskeva, C. (1999). An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: Implications for clonal selection during colorectal carcinogenesis. Oncogene, 18, 3199–3204.
McLean, L. A., Roscoe, J., Jorgensen, N. K., Gorin, F. A., Cala, P. M. (2000). Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. American Journal of Physiology, 278, C676–C688.
Rozhin, J., Sameni, M., Ziegler, G., Sloane, B. F. (1994). Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Research, 54, 6517–6525.
Martinez-Zaguilan, R., Seftor, E. A., Seftor, R. E., Chu, Y. W., Gillies, R. J., & Hendrix, M. J. (1996). Acidic pH enhances the invasive behavior of human melanoma cells. Clinical & Experimental Metastasis, 14, 176–186.
Schlappack, O. K., Zimmermann, A., & Hill, R. P. (1991). Glucose starvation and acidosis: Effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. British Journal of Cancer, 64, 663–670.
Rofstad, E. K., Mathiesen, B., Kindem, K., & Galappathi, K. (2006). Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Research, 66, 6699–6707.
Gilmore, A. P. (2005). Anoikis. Cell Death and Differentiation, 12(Suppl 2), 1473–1477.
Wang, P., Valentijn, A. J., Gilmore, A. P., & Streuli, C. H. (2003). Early events in the anoikis program occur in the absence of caspase activation. Journal of Biological Chemistry, 278, 19917–19925.
Bonnet, S., Archer, S. L., lalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., et al. (2007). A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell, 11, 37–51.
Jordan, B. F., Beghein, N., Crokart, N., Baudelet, C., Gregoire, V., Gallez, B. (2006). Preclinical safety and antitumor efficacy of insulin combined with irradiation. Radiotherapy and Oncology, 81, 112–117.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gillies, R.J., Gatenby, R.A. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 26, 311–317 (2007). https://doi.org/10.1007/s10555-007-9065-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-007-9065-z